{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:18:08Z","timestamp":1788481088691,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China","award":["No. 2017B030314018, No. 2020B1212060026"],"award-info":[{"award-number":["No. 2017B030314018, No. 2020B1212060026"]}]},{"name":"Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China","award":["No. 2015B050501002"],"award-info":[{"award-number":["No. 2015B050501002"]}]},{"name":"Guangdong Provincial Funds for High-end Medical Equipment","award":["No. 2020B1111140003"],"award-info":[{"award-number":["No. 2020B1111140003"]}]},{"name":"Science and Technology Program of Guangzhou, China","award":["No. 202103000007"],"award-info":[{"award-number":["No. 202103000007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81871238"],"award-info":[{"award-number":["No. 81871238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["No. 2021A1515010435"],"award-info":[{"award-number":["No. 2021A1515010435"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01892-2","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T10:43:31Z","timestamp":1749465811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["EZH1 deficiency promotes ferroptosis resistance by activating NRF2 in sepsis-associated liver injury"],"prefix":"10.1186","volume":"17","author":[{"given":"Meihua","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningxin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"8","key":"1892_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"1","key":"1892_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2017","unstructured":"Strnad P, Tacke F, Koch A, Trautwein C. Liver\u2014Guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14(1):55\u201366. https:\/\/doi.org\/10.1038\/nrgastro.2016.168.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1892_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/01.Ccm.0000259462.97164.A0","volume":"35","author":"L Kramer","year":"2007","unstructured":"Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG. Incidence and prognosis of early hepatic dysfunction in critically ill patients\u2013a prospective multicenter study. Crit Care Med. 2007;35(4):1099\u2013104. https:\/\/doi.org\/10.1097\/01.Ccm.0000259462.97164.A0.","journal-title":"Crit Care Med"},{"issue":"1","key":"1892_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/jci82224","volume":"126","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest. 2016;126(1):23\u201331. https:\/\/doi.org\/10.1172\/jci82224.","journal-title":"J Clin Invest"},{"key":"1892_CR5","doi-asserted-by":"publisher","first-page":"671164","DOI":"10.3389\/fphar.2021.671164","volume":"12","author":"P Qiu","year":"2021","unstructured":"Qiu P, Zhou J, Zhang J, Dong Y, Liu Y. Exosome: the regulator of the immune system in sepsis. Front Pharmacol. 2021;12:671164. https:\/\/doi.org\/10.3389\/fphar.2021.671164.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1892_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cell.2017.05.031","volume":"169","author":"S Weis","year":"2017","unstructured":"Weis S, Carlos AR, Moita MR, et al. Metabolic adaptation establishes disease tolerance to sepsis. Cell. 2017;169(7):1263-1275.e14. https:\/\/doi.org\/10.1016\/j.cell.2017.05.031.","journal-title":"Cell"},{"issue":"5","key":"1892_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"1","key":"1892_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/asn.2015121376","volume":"28","author":"D Martin-Sanchez","year":"2017","unstructured":"Martin-Sanchez D, Ruiz-Andres O, Poveda J, et al. Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI. J Am Soc Nephrol. 2017;28(1):218\u201329. https:\/\/doi.org\/10.1681\/asn.2015121376.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1892_CR9","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.1002\/jcp.26576","volume":"233","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhang Q, Gui L, et al. Let-7e inhibits TNF-\u03b1 expression by targeting the methyl transferase EZH2 in DENV2-infected THP-1 cells. J Cell Physiol. 2018;233(11):8605\u201316. https:\/\/doi.org\/10.1002\/jcp.26576.","journal-title":"J Cell Physiol"},{"issue":"13","key":"1892_CR10","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.1073\/pnas.1814634116","volume":"116","author":"M Wassef","year":"2019","unstructured":"Wassef M, Luscan A, Aflaki S, et al. EZH1\/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer. Proc Natl Acad Sci U S A. 2019;116(13):6075\u201380. https:\/\/doi.org\/10.1073\/pnas.1814634116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1892_CR11","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1053\/j.gastro.2019.01.041","volume":"156","author":"JM Grindheim","year":"2019","unstructured":"Grindheim JM, Nicetto D, Donahue G, Zaret KS. Polycomb repressive complex 2 proteins EZH1 and EZH2 regulate timing of postnatal hepatocyte maturation and fibrosis by repressing genes with euchromatic promoters in mice. Gastroenterology. 2019;156(6):1834\u201348. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.041.","journal-title":"Gastroenterology"},{"issue":"12","key":"1892_CR12","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.3390\/ijms22126249","volume":"22","author":"J Jang","year":"2021","unstructured":"Jang J, Song J, Sim I, Kwon YV, Yoon Y. Wnt-signaling inhibitor Wnt-C59 suppresses the cytokine upregulation in multiple organs of lipopolysaccharide-induced endotoxemic mice via reducing the interaction between \u03b2-catenin and NF-\u03baB. Int J Mol Sci. 2021;22(12):6249. https:\/\/doi.org\/10.3390\/ijms22126249.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1892_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nprot.2008.214","volume":"4","author":"D Rittirsch","year":"2009","unstructured":"Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 2009;4(1):31\u20136. https:\/\/doi.org\/10.1038\/nprot.2008.214.","journal-title":"Nat Protoc"},{"issue":"2","key":"1892_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/hep.24701","volume":"55","author":"R Urtasun","year":"2012","unstructured":"Urtasun R, Lopategi A, George J, et al. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)beta(3) engagement and PI3K\/pAkt\/NFkappaB signaling. Hepatology. 2012;55(2):594\u2013608. https:\/\/doi.org\/10.1002\/hep.24701.","journal-title":"Hepatology"},{"issue":"10","key":"1892_CR15","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/cas.13326","volume":"108","author":"D Honma","year":"2017","unstructured":"Honma D, Kanno O, Watanabe J, et al. Novel orally bioavailable EZH1\/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor. Cancer Sci. 2017;108(10):2069\u201378. https:\/\/doi.org\/10.1111\/cas.13326.","journal-title":"Cancer Sci"},{"issue":"1","key":"1892_CR16","doi-asserted-by":"publisher","first-page":"e53741","DOI":"10.1371\/journal.pone.0053741","volume":"8","author":"L Lorente","year":"2013","unstructured":"Lorente L, Mart\u00edn MM, Abreu-Gonz\u00e1lez P, et al. Prognostic value of malondialdehyde serum levels in severe sepsis: a multicenter study. PLoS ONE. 2013;8(1):e53741. https:\/\/doi.org\/10.1371\/journal.pone.0053741.","journal-title":"PLoS ONE"},{"key":"1892_CR17","doi-asserted-by":"publisher","first-page":"5080843","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"LJ Su","year":"2019","unstructured":"Su LJ, Zhang JH, Gomez H, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev. 2019;2019:5080843. https:\/\/doi.org\/10.1155\/2019\/5080843.","journal-title":"Oxid Med Cell Longev"},{"key":"1892_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.freeradbiomed.2013.07.013","volume":"65","author":"X Wen","year":"2013","unstructured":"Wen X, Wu J, Wang F, Liu B, Huang C, Wei Y. Deconvoluting the role of reactive oxygen species and autophagy in human diseases. Free Radical Biol Med. 2013;65:402\u201310. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.07.013.","journal-title":"Free Radical Biol Med"},{"issue":"6","key":"1892_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/iub.1616","volume":"69","author":"S Doll","year":"2017","unstructured":"Doll S, Conrad M. Iron and ferroptosis: a still ill-defined liaison. IUBMB Life. 2017;69(6):423\u201334. https:\/\/doi.org\/10.1002\/iub.1616.","journal-title":"IUBMB Life"},{"issue":"1\u20132","key":"1892_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mrfmmm.2003.08.004","volume":"531","author":"M Kruszewski","year":"2003","unstructured":"Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res. 2003;531(1\u20132):81\u201392. https:\/\/doi.org\/10.1016\/j.mrfmmm.2003.08.004.","journal-title":"Mutat Res"},{"issue":"8","key":"1892_CR21","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","volume":"1861","author":"GO Latunde-Dada","year":"2017","unstructured":"Latunde-Dada GO. Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta. 2017;1861(8):1893\u2013900. https:\/\/doi.org\/10.1016\/j.bbagen.2017.05.019.","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"1892_CR22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1089\/ars.2021.0027","volume":"35","author":"J Joffre","year":"2021","unstructured":"Joffre J, Hellman J. Oxidative stress and endothelial dysfunction in sepsis and acute inflammation. Antioxid Redox Signal. 2021;35(15):1291\u2013307. https:\/\/doi.org\/10.1089\/ars.2021.0027.","journal-title":"Antioxid Redox Signal"},{"issue":"2\u20134","key":"1892_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0009-3084(87)90063-6","volume":"45","author":"G Poli","year":"1987","unstructured":"Poli G, Albano E, Dianzani MU. The role of lipid peroxidation in liver damage. Chem Phys Lipids. 1987;45(2\u20134):117\u201342. https:\/\/doi.org\/10.1016\/0009-3084(87)90063-6.","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"1892_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1476-5381.2011.01480.x","volume":"165","author":"RJ Bridges","year":"2012","unstructured":"Bridges RJ, Natale NR, Patel SA. System xc\u207b cystine\/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol. 2012;165(1):20\u201334. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01480.x.","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"1892_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010.","journal-title":"Cell"},{"issue":"5","key":"1892_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nsmb.3392","volume":"24","author":"B Bodega","year":"2017","unstructured":"Bodega B, Marasca F, Ranzani V, et al. A cytosolic Ezh1 isoform modulates a PRC2-Ezh1 epigenetic adaptive response in postmitotic cells. Nat Struct Mol Biol. 2017;24(5):444\u201352. https:\/\/doi.org\/10.1038\/nsmb.3392.","journal-title":"Nat Struct Mol Biol"},{"key":"1892_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13072-019-0322-5","volume":"12","author":"P Liu","year":"2019","unstructured":"Liu P, Shuaib M, Zhang H, Nadeef S, Orlando V. Ubiquitin ligases HUWE1 and NEDD4 cooperatively control signal-dependent PRC2-Ezh1\u03b1\/\u03b2-mediated adaptive stress response pathway in skeletal muscle cells. Epigenet Chromatin. 2019;12:1\u20133. https:\/\/doi.org\/10.1186\/s13072-019-0322-5.","journal-title":"Epigenet Chromatin"},{"issue":"1","key":"1892_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M de Rojo la Vega","year":"2018","unstructured":"de Rojo la Vega M, Chapman E, Zhang DD. NRF2 and the hallmarks of cancer. Cancer Cell. 2018;34(1):21\u201343. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.022.","journal-title":"Cancer Cell"},{"issue":"36","key":"1892_CR29","doi-asserted-by":"publisher","first-page":"13568","DOI":"10.1073\/pnas.0806268105","volume":"105","author":"T Shibata","year":"2008","unstructured":"Shibata T, Ohta T, Tong KI, et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A. 2008;105(36):13568\u201373. https:\/\/doi.org\/10.1073\/pnas.0806268105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1892_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"27","author":"A Anandhan","year":"2020","unstructured":"Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD. Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol. 2020;27(4):436\u201347. https:\/\/doi.org\/10.1016\/j.chembiol.2020.03.011.","journal-title":"Cell Chem Biol"},{"issue":"7","key":"1892_CR31","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1080\/10428194.2018.1430795","volume":"59","author":"N Gulati","year":"2018","unstructured":"Gulati N, B\u00e9guelin W, Giulino-Roth L. Enhancer of zeste homolog 2 (EZH2) inhibitors. Leuk Lymphoma. 2018;59(7):1574\u201385. https:\/\/doi.org\/10.1080\/10428194.2018.1430795.","journal-title":"Leuk Lymphoma"},{"issue":"24","key":"1892_CR32","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1158\/0008-5472.Can-20-2147","volume":"80","author":"ML Eich","year":"2020","unstructured":"Eich ML, Athar M, Ferguson JE 3rd, Varambally S. EZH2-targeted therapies in cancer: hype or a reality. Cancer Res. 2020;80(24):5449\u201358. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-2147.","journal-title":"Cancer Res"},{"issue":"12","key":"1892_CR33","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/tcr.201800091","volume":"18","author":"R Fioravanti","year":"2018","unstructured":"Fioravanti R, Stazi G, Zwergel C, Valente S, Mai A. Six years (2012\u20132018) of researches on catalytic EZH2 inhibitors: the boom of the 2-pyridone compounds. Chem Record (New York, NY). 2018;18(12):1818\u201332. https:\/\/doi.org\/10.1002\/tcr.201800091.","journal-title":"Chem Record (New York, NY)"},{"issue":"10","key":"1892_CR34","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1182\/blood.2022016862","volume":"141","author":"K Izutsu","year":"2023","unstructured":"Izutsu K, Makita S, Nosaka K, Yoshimitsu M, Utsunomiya A, Kusumoto S, Morishima S, Tsukasaki K, Kawamata T, Ono T, Rai S. An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia\/lymphoma. Blood. 2023;141(10):1159\u201368. https:\/\/doi.org\/10.1182\/blood.2022016862.","journal-title":"Blood"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01892-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01892-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01892-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T10:43:32Z","timestamp":1749465812000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01892-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1892"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01892-2","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that the study was conducted in the absence of any commercial or financial relationships, and there are no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}